The Best Peptides for Memory and Cognitive Function: Dihexa, Cerebrolysin, Semax, Selank, and More
Peptides targeting the central nervous system represent the frontier of research into cognitive enhancement, neuroprotection, and neuroplasticity. From compounds with decades of clinical use to cutting-edge experimental molecules, this guide covers the most studied and most promising options available today.
For Educational & Research Purposes Only
This article is an educational resource. Nothing here constitutes medical advice. Cognitive peptides include compounds with limited human safety data. Always consult a licensed healthcare provider before beginning any peptide protocol.
How Cognitive Peptides Work
Cognitive peptides work through several distinct mechanisms: upregulation of neurotrophic factors (BDNF, NGF, HGF), modulation of neurotransmitter systems (dopaminergic, serotonergic, GABAergic), direct synaptogenesis (new synaptic connection formation), neuroprotection from oxidative stress and inflammation, and metabolic support for neuronal energy demands. The most effective cognitive protocols target multiple mechanisms simultaneously — combining a fast-acting neurotransmitter modulator with a longer-term neuroplasticity compound and metabolic support.
What distinguishes this category from general nootropics is the structural specificity of peptides. Unlike small molecules that broadly affect receptor populations, peptides tend to work through specific receptor systems and signaling pathways — producing more targeted effects with generally cleaner side effect profiles.
Peptide Profiles
Dihexa is a small peptide derived from angiotensin IV research, and it is currently considered one of the most potent cognitive-enhancing compounds known. It works by facilitating hepatocyte growth factor (HGF) binding to its MET receptor — a pathway deeply involved in synaptogenesis (the formation of new synaptic connections). In animal models, Dihexa has demonstrated improvements in spatial memory and executive function that outperform BDNF (brain-derived neurotrophic factor) by several orders of magnitude in potency. Its lipophilic structure allows it to cross the blood-brain barrier readily, and it appears to have sustained effects even after discontinuation. This is an advanced compound with limited human safety data — it deserves the highest level of informed caution.
Typical Research Dosing
Oral: 10–15 mg, 1–2x weekly. Topical formulations allow transdermal delivery for local CNS uptake. Due to potency, many researchers start at lower doses and monitor carefully.
- Estimated 10 million times more potent than BDNF in some animal models for synaptogenesis
- Crosses the blood-brain barrier efficiently due to lipophilicity
- Effects may persist beyond the dosing period — suggesting durable structural changes
- Very limited human safety data — treat as advanced, high-caution compound
Cerebrolysin is a standardized mixture of low-molecular-weight neuropeptides derived from purified porcine brain proteins. Unlike single-compound peptides, Cerebrolysin contains a diverse array of peptide fragments that collectively mimic the action of endogenous neurotrophic factors including BDNF, NGF, and CNTF. It has an extensive clinical track record in Europe and Asia as an approved treatment for stroke recovery, traumatic brain injury, dementia, and Alzheimer's disease. For healthy researchers, Cerebrolysin is studied for its neuroprotective and potentially neurogenic properties — the ability to protect existing neurons and support the growth of new connections. Its clinical precedent makes it one of the most evidence-backed peptides in the cognitive category.
Typical Research Dosing
5–10 ml IV or IM, daily for 10–20 day cycles. Standard clinical protocol: 10 ml/day for 20 days, repeat quarterly.
- Approved drug in over 40 countries for neurological conditions
- Strong clinical trial data for stroke recovery and Alzheimer's disease
- Promotes BDNF, NGF, and CNTF — major endogenous neurotrophic factors
- Used cyclically — clinical protocols typically run 10–20 day courses
Semax is a synthetic heptapeptide analogue of the N-terminal fragment of ACTH, developed in Russia in the 1980s and approved there for clinical use in stroke, TBI, and cognitive disorders. It works through several pathways: direct upregulation of BDNF and its receptor TrkB, modulation of dopaminergic and serotonergic systems, and anti-inflammatory effects in the CNS. Researchers report effects including heightened focus, improved processing speed, better working memory, and enhanced executive function. Semax is available as an injectable or nasal spray — the nasal route allows direct delivery to olfactory epithelium with rapid CNS uptake.
Typical Research Dosing
Nasal spray: 600 mcg–1200 mcg per day (2–3 sprays of 600 mcg/spray). Injectable: 100–300 mcg subcutaneous. Cycle 2–4 weeks on, 2–4 weeks off.
- Approved drug in Russia for cognitive disorders and stroke recovery
- Upregulates BDNF and TrkB — key mediators of neuroplasticity
- Available as nasal spray for non-injection administration
- Pairs well with Selank for comprehensive cognitive and anxiolytic coverage
Selank is a synthetic analogue of the endogenous tetrapeptide tuftsin, developed alongside Semax at the Institute of Molecular Genetics in Moscow. Where Semax is primarily activating and performance-focused, Selank occupies a complementary role — it is an anxiolytic with cognitive-enhancing secondary effects. Its primary mechanism involves stabilization of enkephalins (endogenous opioid peptides), which reduces anxiety without the sedation or dependence risk of benzodiazepines. It also modulates serotonin, dopamine, and GABA systems, and shows neuroprotective properties. Researchers often use Selank and Semax together — one providing stimulating cognitive enhancement while the other manages anxiety and mood, creating a balanced cognitive experience.
Typical Research Dosing
Nasal spray: 750 mcg–1500 mcg per day. Injectable: 250–500 mcg subcutaneous. Cycle similar to Semax.
- Approved drug in Russia for anxiety disorders
- Non-habit-forming anxiolytic — no withdrawal or dependence in research
- Modulates serotonin metabolism and GABA-A receptor sensitivity
- Classic pairing with Semax: one activating, one calming for balanced cognition
Epithalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) that mimics the activity of epithalamin — a natural extract from the pineal gland used in anti-aging research for decades in the Soviet Union and Russia. Its primary studied mechanism is activation of telomerase, the enzyme responsible for maintaining telomere length. Shorter telomeres are associated with cellular aging; Epithalon's telomerase activation theoretically supports cellular longevity and delayed senescence. In the context of cognitive function specifically, Epithalon demonstrates neuroprotective effects, normalizes melatonin production, and improves circadian rhythm regulation — all of which have downstream effects on memory consolidation and cognitive performance.
Typical Research Dosing
5–10 mg subcutaneous, daily for 10–20 day cycles, 1–2x annually.
- Activates telomerase — studied mechanism for anti-aging effects at the cellular level
- Normalizes pineal function and melatonin secretion
- Neuroprotective in animal aging models
- Typically used in cycles of 10–20 days, 1–2 times per year
While not a traditional peptide, NAD+ (Nicotinamide Adenine Dinucleotide) is frequently used alongside cognitive peptide protocols due to its fundamental role in neuronal energy metabolism, DNA repair, and sirtuin activation. NAD+ declines significantly with age, and neurons — which have extremely high energy demands — are particularly susceptible to this decline. IV NAD+ therapy or subcutaneous injection produces rapid CNS effects including mental clarity, reduced brain fog, and mood improvement. In the context of a cognitive peptide stack, NAD+ serves as foundational metabolic support that amplifies the effectiveness of more targeted compounds.
Typical Research Dosing
100–500 mg IV infusion (slow drip over 2–4 hours) or 100 mg subcutaneous daily.
- Declines 50%+ by age 50 — supplementation addresses a real age-related deficit
- Activates sirtuins (SIRT1, SIRT3) — linked to longevity and stress resilience
- IV administration produces rapid, pronounced cognitive effects
- Supports mitochondrial efficiency — particularly critical for high-energy neurons
Building a Cognitive Peptide Stack
The Foundation Stack: Semax + Selank
Semax provides the activating, focus-enhancing, BDNF-upregulating effect. Selank provides complementary anxiolytic and mood-stabilizing support. Together, they address both cognitive performance and the anxious edge that performance-focused compounds can sometimes produce. This pairing is widely used in Russian clinical research and is a natural starting point for researchers new to cognitive peptides.
Adding Dihexa for Deeper Neuroplasticity
For researchers targeting synaptic density and long-term structural neuroplasticity — not just acute cognitive performance — Dihexa is added to the stack. Due to its potency and the limited human safety data, most researchers use it infrequently (weekly or less) and at conservative doses. Its effects appear to persist after discontinuation, which makes careful dosing especially important.
Cerebrolysin for Neuroprotection and Recovery
Cerebrolysin is most commonly run in separate intensive cycles (10–20 days) rather than daily. Its profile is neuroprotective — it is most valuable when brain tissue is under stress (post-injury, during aging, after illness) or when a 'reset' of neurotrophin signaling is the goal. It can be cycled alongside Semax/Selank or used independently.
NAD+ as Metabolic Substrate
All cognitive enhancement is ultimately limited by the metabolic capacity of neurons. NAD+ supplementation addresses the energy substrate layer — ensuring neurons have the cofactor availability needed to support increased synaptic activity. Many researchers run an NAD+ protocol once or twice yearly as a foundation before adding more targeted compounds.
Other Articles
Calculator
Calculate exact reconstitution volumes and insulin unit doses for any peptide protocol.
Open Calculator →